Advertisement

Index by author

March 01, 1994; Volume 268,Issue 3

A

  1. Abdel-Latif, A A

    1. Characterization of iris sphincter smooth muscle endothelin receptor subtypes which are coupled to cyclic AMP formation and polyphosphoinositide hydrolysis.
      A M el-Mowafy and A A Abdel-Latif
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1343-1351;

  2. Acara, M

    1. Uptake and phosphorylation of thiamine in rat kidney cortical slices. I. Effect of ethanol.
      M A Mahajan and M Acara
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1311-1315;
    2. Uptake and phosphorylation of thiamine in rabbit primary proximal tubule cells and Madin Darby canine kidney cells. II. Effect of ethanol.
      M A Mahajan, M Acara and M Taub
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1316-1320;

  3. Adrien, J

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  4. Ahluwalia, A

    1. Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors.
      A Ahluwalia and M Perretti
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1526-1531;

  5. Aksu, F

    1. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
      J J Rady, F Aksu and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1222-1231;

  6. Akunne, H C

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  7. Ali, S

    1. Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor.
      S Ali, S J Mustafa and W J Metzger
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1328-1334;

  8. Altura, B M

    1. Cocaine-induced cerebrovasospasm and its possible mechanism of action.
      G Q He, A Zhang, B T Altura and B M Altura
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1532-1539;

  9. Altura, B T

    1. Cocaine-induced cerebrovasospasm and its possible mechanism of action.
      G Q He, A Zhang, B T Altura and B M Altura
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1532-1539;

  10. Archer, S

    1. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
      Q Jiang, A Sebastian, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1107-1113;

  11. Audebert, F

    1. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
      F Audebert, M Urtizberea, A Sabouraud, J M Scherrmann and C Bon
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1512-1517;

B

  1. Bandyopadhyay, A M

    1. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
      P N Zannikos, A M Bandyopadhyay, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1565-1570;

  2. Barajas-López, C

    1. ATP closes a potassium and opens a cationic conductance through different receptors in neurons of guinea pig submucous plexus.
      C Barajas-López, R Espinosa-Luna and V Gerzanich
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1397-1402;

  3. BARAJAS-LÓPEZ, CARLOS

    1. ATP Closes a Potassium and Opens a Cationic Conductance through Different Receptors in Neurons of Guinea Pig Submucous Plexus
      CARLOS BARAJAS-LÓPEZ, ROSA ESPINOSA-LUNA and VLADIMIR GERZANICH
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1396-1402;

  4. Barrett, R J

    1. Discrimination of A1 versus A2 receptor subtype selectivity of adenosine receptor agonists in vivo.
      R J Barrett, D A Droppleman and K F Wright
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1166-1173;

  5. Bass, P

    1. Increased active stress generation of denervated rat intestinal smooth muscle: functional analysis of muscarinic receptor population.
      M A Osinski and P Bass
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1368-1373;

  6. Baumann, M H

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  7. Baumgartner, A

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  8. Bayer, B M

    1. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors.
      L R Flores, M C Hernandez and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1129-1134;

  9. Beauregard, C L

    1. Parasympathetic innervation of rat peri-orbital smooth muscle: prejunctional cholinergic inhibition of sympathetic neurotransmission without direct postjunctional actions.
      C L Beauregard and P G Smith
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1284-1288;

  10. Beckman, J S

    1. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs.
      S Liu, J S Beckman and D D Ku
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1114-1121;

  11. Berke, G

    1. Calcium channel blockers modify electrophysiological effects induced by lytic granules from cytotoxic T lymphocytes in guinea pig ventricular myocytes.
      O Binah, G Berke, D Rosen and B F Hoffman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1581-1587;

  12. Berlan, M

    1. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
      M Berlan, J Galitzky, A Bousquet-Melou, M Lafontan and J L Montastruc
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1444-1451;

  13. Bianchi, J

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  14. Bidlack, J M

    1. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
      Q Jiang, A Sebastian, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1107-1113;

  15. Binah, O

    1. Calcium channel blockers modify electrophysiological effects induced by lytic granules from cytotoxic T lymphocytes in guinea pig ventricular myocytes.
      O Binah, G Berke, D Rosen and B F Hoffman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1581-1587;

  16. Blaxall, H S

    1. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
      M F O'Rourke, H S Blaxall, L J Iversen and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1362-1367;

  17. Blouin, R A

    1. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
      P N Zannikos, A M Bandyopadhyay, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1565-1570;

  18. Blue, D R

    1. Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.
      D R Blue, D A Craig, J T Ransom, J A Camacho, P A Insel and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1588-1596;

  19. Bon, C

    1. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
      F Audebert, M Urtizberea, A Sabouraud, J M Scherrmann and C Bon
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1512-1517;

  20. Bonizzoni, E

    1. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
      C Casati, A Monopoli, S Dionisotti, C Zocchi, E Bonizzoni and E Ongini
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1506-1511;

  21. Bousquet-Melou, A

    1. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
      M Berlan, J Galitzky, A Bousquet-Melou, M Lafontan and J L Montastruc
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1444-1451;

  22. Bowyer, J F

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  23. Broening, H W

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  24. Brooks, D P

    1. Characterization of canine renal endothelin receptor subtypes and their function.
      D P Brooks, P D DePalma, M Pullen and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1091-1097;

  25. Bylund, D B

    1. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
      M F O'Rourke, H S Blaxall, L J Iversen and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1362-1367;

C

  1. Cadet, J L

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  2. Caillé, G

    1. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
      G Rousseau, P Provost, D Tran, G Caillé and J G Latour
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1252-1260;

  3. Calogero, A E

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  4. Camacho, J A

    1. Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.
      D R Blue, D A Craig, J T Ransom, J A Camacho, P A Insel and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1588-1596;

  5. Cami, J

    1. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
      X Lamas, M Farre and J Cami
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1485-1492;

  6. Campos-Barros, A

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  7. Carlen, P L

    1. Potentiation of GABAA-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C.
      J L Weiner, L Zhang and P L Carlen
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1388-1395;

  8. Carroll, F I

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  9. Casati, C

    1. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
      C Casati, A Monopoli, S Dionisotti, C Zocchi, E Bonizzoni and E Ongini
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1506-1511;

  10. Cavero, I

    1. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
      M Magnon, I Durand and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1411-1418;

  11. Chai, B L

    1. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
      H Y Meltzer, B L Chai, P A Thompson and B K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1452-1461;

  12. Char, G U

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  13. Cheng, C P

    1. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
      C P Cheng, T Noda, M Nordlander, M Ohno and W C Little
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1232-1241;

  14. Choudhary, M S

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  15. Christ, D D

    1. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
      D D Christ, P C Wong, Y N Wong, S D Hart, C Y Quon and G N Lam
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1199-1205;

  16. Ciaranello, R D

    1. Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors.
      M A Harrington, K Shaw, P Zhong and R D Ciaranello
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1098-1106;

  17. Clarke, D E

    1. Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.
      D R Blue, D A Craig, J T Ransom, J A Camacho, P A Insel and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1588-1596;

  18. Code, R A

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  19. Coffey, R G

    1. The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells.
      S Diaz, S Specter, J Y Vanderhoek and R G Coffey
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1289-1296;

  20. Conley, K

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  21. Coppola, R

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  22. Cotreau-Bibbo, M M

    1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
      L L von Moltke, D J Greenblatt, M M Cotreau-Bibbo, S X Duan, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1278-1283;

  23. Cowdry, R W

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  24. Craig, D A

    1. Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.
      D R Blue, D A Craig, J T Ransom, J A Camacho, P A Insel and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1588-1596;

  25. Craigo, S C

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  26. Crowther, R

    1. Functional subtyping of neurokinin receptors on canine proximal colonic mucosa.
      R Crowther, D Jukic, D Regoli and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1374-1380;

D

  1. Dagerlind, A

    1. Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney.
      B Meister, A Dagerlind, A P Nicholas and T Hökfelt
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1605-1611;

  2. Davies, D L

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  3. Day, B

    1. Contraction of the guinea pig isolated, perfused trachea to purine and pyrimidine agonists.
      J S Fedan, J L Stem and B Day
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1321-1327;

  4. de Costa, B R

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  5. Deleve, L D

    1. Dacarbazine toxicity in murine liver cells: a model of hepatic endothelial injury and glutathione defense.
      L D Deleve
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1261-1270;

  6. DePalma, P D

    1. Characterization of canine renal endothelin receptor subtypes and their function.
      D P Brooks, P D DePalma, M Pullen and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1091-1097;

  7. Dersch, C M

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  8. Diaz, S

    1. The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells.
      S Diaz, S Specter, J Y Vanderhoek and R G Coffey
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1289-1296;

  9. Dionisotti, S

    1. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
      C Casati, A Monopoli, S Dionisotti, C Zocchi, E Bonizzoni and E Ongini
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1506-1511;

  10. Djuric, S W

    1. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
      B S Tsai, R H Keith, D Villani-Price, R A Haack and S W Djuric
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1493-1498;
    2. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

  11. Droppleman, D A

    1. Discrimination of A1 versus A2 receptor subtype selectivity of adenosine receptor agonists in vivo.
      R J Barrett, D A Droppleman and K F Wright
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1166-1173;

  12. Duan, S X

    1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
      L L von Moltke, D J Greenblatt, M M Cotreau-Bibbo, S X Duan, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1278-1283;

  13. Duckles, S P

    1. Influence of gender on vascular reactivity in the rat.
      Z Li and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1426-1431;

  14. Durand, I

    1. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
      M Magnon, I Durand and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1411-1418;

E

  1. Echizen, H

    1. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
      H Echizen, K Mochizuki, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1518-1525;

  2. Egawa, M

    1. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.
      T Watanabe, S Yuki, M Egawa and H Nishi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1597-1604;

  3. Eisenhofer, G

    1. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
      G Eisenhofer and J P Finberg
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1242-1251;

  4. el-Mowafy, A M

    1. Characterization of iris sphincter smooth muscle endothelin receptor subtypes which are coupled to cyclic AMP formation and polyphosphoinositide hydrolysis.
      A M el-Mowafy and A A Abdel-Latif
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1343-1351;

  5. Eravci, M

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  6. Espinosa-Luna, R

    1. ATP closes a potassium and opens a cationic conductance through different receptors in neurons of guinea pig submucous plexus.
      C Barajas-López, R Espinosa-Luna and V Gerzanich
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1397-1402;

  7. ESPINOSA-LUNA, ROSA

    1. ATP Closes a Potassium and Opens a Cationic Conductance through Different Receptors in Neurons of Guinea Pig Submucous Plexus
      CARLOS BARAJAS-LÓPEZ, ROSA ESPINOSA-LUNA and VLADIMIR GERZANICH
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1396-1402;

  8. Evans, D M

    1. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
      D M Evans, J T Lake, M R Johnson and A C Howlett
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1271-1277;

F

  1. Farre, M

    1. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
      X Lamas, M Farre and J Cami
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1485-1492;

  2. Fattaccini, C M

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  3. Fedan, J S

    1. Contraction of the guinea pig isolated, perfused trachea to purine and pyrimidine agonists.
      J S Fedan, J L Stem and B Day
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1321-1327;

  4. Finberg, J P

    1. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
      G Eisenhofer and J P Finberg
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1242-1251;

  5. Fleming, W W

    1. Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat.
      J Q Kong, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1153-1159;

  6. Flores, L R

    1. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors.
      L R Flores, M C Hernandez and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1129-1134;

  7. Franklin, S R

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  8. Fujimoto, J M

    1. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
      J J Rady, F Aksu and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1222-1231;

  9. Fujimoto, M

    1. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139.
      S Mihara, S Nakajima, S Matumura, T Kohnoike and M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1122-1128;

G

  1. Galitzky, J

    1. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
      M Berlan, J Galitzky, A Bousquet-Melou, M Lafontan and J L Montastruc
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1444-1451;

  2. Gardner, D L

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  3. Gerzanich, V

    1. ATP closes a potassium and opens a cationic conductance through different receptors in neurons of guinea pig submucous plexus.
      C Barajas-López, R Espinosa-Luna and V Gerzanich
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1397-1402;

  4. GERZANICH, VLADIMIR

    1. ATP Closes a Potassium and Opens a Cationic Conductance through Different Receptors in Neurons of Guinea Pig Submucous Plexus
      CARLOS BARAJAS-LÓPEZ, ROSA ESPINOSA-LUNA and VLADIMIR GERZANICH
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1396-1402;

  5. Giri, S N

    1. Antithetical actions of mitoxantrone and doxorubicin on ryanodine-sensitive Ca++ release channels of rat cardiac sarcoplasmic reticulum: evidence for a competitive mechanism.
      E Kim, S N Giri and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1212-1221;

  6. Gozlan, H

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  7. Greenberg, S S

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  8. Greenblatt, D J

    1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
      L L von Moltke, D J Greenblatt, M M Cotreau-Bibbo, S X Duan, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1278-1283;

  9. Gross, A S

    1. Interaction of the stereoisomers of basic drugs with the uptake of tetraethylammonium by rat renal brush-border membrane vesicles.
      A S Gross and A A Somogyi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1073-1080;

H

  1. Haack, R A

    1. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
      B S Tsai, R H Keith, D Villani-Price, R A Haack and S W Djuric
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1493-1498;

  2. Haj-Dahmane, S

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  3. Harmatz, J S

    1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
      L L von Moltke, D J Greenblatt, M M Cotreau-Bibbo, S X Duan, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1278-1283;

  4. Harrington, M A

    1. Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors.
      M A Harrington, K Shaw, P Zhong and R D Ciaranello
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1098-1106;

  5. Hart, M J

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  6. Hart, S D

    1. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
      D D Christ, P C Wong, Y N Wong, S D Hart, C Y Quon and G N Lam
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1199-1205;

  7. Hasler, W L

    1. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.
      W L Hasler, H C Soudah and C Owyang
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1206-1211;

  8. He, G Q

    1. Cocaine-induced cerebrovasospasm and its possible mechanism of action.
      G Q He, A Zhang, B T Altura and B M Altura
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1532-1539;

  9. Herkenham, M

    1. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.
      A B Lynn and M Herkenham
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1612-1623;

  10. Hernandez, M C

    1. Acute immunosuppressive effects of morphine: lack of involvement of pituitary and adrenal factors.
      L R Flores, M C Hernandez and B M Bayer
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1129-1134;

  11. Hoffman, B F

    1. Calcium channel blockers modify electrophysiological effects induced by lytic granules from cytotoxic T lymphocytes in guinea pig ventricular myocytes.
      O Binah, G Berke, D Rosen and B F Hoffman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1581-1587;

  12. Hoffmann, W E

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  13. Hökfelt, T

    1. Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney.
      B Meister, A Dagerlind, A P Nicholas and T Hökfelt
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1605-1611;

  14. Holloway, D

    1. A unique central cholinergic deficit in the spontaneously hypertensive rat: physostigmine reveals a bradycardia associated with sensory stimulation.
      B K Taylor, D Holloway and M P Printz
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1081-1090;

  15. Holson, R R

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  16. Howlett, A C

    1. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
      D M Evans, J T Lake, M R Johnson and A C Howlett
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1271-1277;

  17. Hudzik, T J

    1. Drug effects on response-duration differentiation. II: Selective effects of antidepressant drugs.
      T J Hudzik and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1335-1342;

I

  1. Inada, Y

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  2. Insel, P A

    1. Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.
      D R Blue, D A Craig, J T Ransom, J A Camacho, P A Insel and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1588-1596;

  3. Iqbal, Z

    1. Ethanol modulates [125I]calmodulin binding to synaptic plasma membranes from rat brain.
      P Y Sze and Z Iqbal
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1183-1189;

  4. Ishizaki, T

    1. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
      H Echizen, K Mochizuki, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1518-1525;

  5. Itoh, K

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  6. Iversen, L J

    1. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
      M F O'Rourke, H S Blaxall, L J Iversen and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1362-1367;

J

  1. Jiang, Q

    1. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
      Q Jiang, A Sebastian, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1107-1113;

  2. Johns, A

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  3. Johnson, M R

    1. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
      D M Evans, J T Lake, M R Johnson and A C Howlett
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1271-1277;

  4. Jolas, T

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  5. Jukic, D

    1. Functional subtyping of neurokinin receptors on canine proximal colonic mucosa.
      R Crowther, D Jukic, D Regoli and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1374-1380;

K

  1. Kachur, J F

    1. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

  2. Keith, R H

    1. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
      B S Tsai, R H Keith, D Villani-Price, R A Haack and S W Djuric
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1493-1498;
    2. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

  3. Kellner, C H

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  4. Kennedy, R H

    1. Effects of WB4101 and chloroethylclonidine on the positive and negative inotropic actions of phenylephrine in rat cardiac muscle.
      A P Williamson, E Seifen, J P Lindemann and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1174-1182;

  5. Kidd, E J

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  6. Kim, E

    1. Antithetical actions of mitoxantrone and doxorubicin on ryanodine-sensitive Ca++ release channels of rat cardiac sarcoplasmic reticulum: evidence for a competitive mechanism.
      E Kim, S N Giri and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1212-1221;

  7. Kleha, J

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  8. Kling, M A

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  9. Kohara, Y

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  10. Köhler, R

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  11. Kohnoike, T

    1. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139.
      S Mihara, S Nakajima, S Matumura, T Kohnoike and M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1122-1128;

  12. Kong, J Q

    1. Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat.
      J Q Kong, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1153-1159;

  13. Ku, D D

    1. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs.
      S Liu, J S Beckman and D D Ku
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1114-1121;

  14. Kubo, K

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  15. Kumar, G N

    1. Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation.
      G N Kumar, U K Walle and T Walle
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1160-1165;

L

  1. Lafontan, M

    1. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
      M Berlan, J Galitzky, A Bousquet-Melou, M Lafontan and J L Montastruc
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1444-1451;

  2. Lahti, R A

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  3. Lake, J T

    1. Endogenous cannabinoid receptor binding activity released from rat brain slices by depolarization.
      D M Evans, J T Lake, M R Johnson and A C Howlett
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1271-1277;

  4. Lam, G N

    1. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
      D D Christ, P C Wong, Y N Wong, S D Hart, C Y Quon and G N Lam
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1199-1205;

  5. Lamas, X

    1. Acute effects of pentazocine, naloxone and morphine in opioid-dependent volunteers.
      X Lamas, M Farre and J Cami
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1485-1492;

  6. Lanfumey, L

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  7. Langlois, X

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  8. Laporte, A M

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  9. Latour, J G

    1. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
      G Rousseau, P Provost, D Tran, G Caillé and J G Latour
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1252-1260;

  10. Lee, K S

    1. A selective blocker for rested T-type Ca++ channels in guinea pig atrial cells.
      X Xu and K S Lee
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1135-1142;

  11. Lefter, L

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  12. Li, Z

    1. Influence of gender on vascular reactivity in the rat.
      Z Li and S P Duckles
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1426-1431;

  13. Lindemann, J P

    1. Effects of WB4101 and chloroethylclonidine on the positive and negative inotropic actions of phenylephrine in rat cardiac muscle.
      A P Williamson, E Seifen, J P Lindemann and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1174-1182;

  14. Little, W C

    1. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
      C P Cheng, T Noda, M Nordlander, M Ohno and W C Little
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1232-1241;

  15. Liu, S

    1. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs.
      S Liu, J S Beckman and D D Ku
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1114-1121;

  16. Lum-Ragan, J T

    1. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
      M F Piercey, M W Smith and J T Lum-Ragan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1297-1303;
    2. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  17. Lynn, A B

    1. Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.
      A B Lynn and M Herkenham
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1612-1623;

M

  1. Magnon, M

    1. The contribution of guanylate cyclase stimulation and K+ channel opening to nicorandil-induced vasorelaxation depends on the conduit vessel and on the nature of the spasmogen.
      M Magnon, I Durand and I Cavero
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1411-1418;

  2. Mahajan, M A

    1. Uptake and phosphorylation of thiamine in rat kidney cortical slices. I. Effect of ethanol.
      M A Mahajan and M Acara
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1311-1315;
    2. Uptake and phosphorylation of thiamine in rabbit primary proximal tubule cells and Madin Darby canine kidney cells. II. Effect of ethanol.
      M A Mahajan, M Acara and M Taub
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1316-1320;

  3. Marceau, F

    1. Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade.
      E Petitclerc, P E Poubelle and F Marceau
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1419-1425;

  4. Martin, B R

    1. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
      P B Smith, S P Welch and B R Martin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1381-1387;

  5. Matumura, S

    1. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139.
      S Mihara, S Nakajima, S Matumura, T Kohnoike and M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1122-1128;

  6. McCall, R B

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  7. McMillan, D E

    1. Drug effects on response-duration differentiation. II: Selective effects of antidepressant drugs.
      T J Hudzik and D E McMillan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1335-1342;

  8. Meinhold, H

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  9. Meister, B

    1. Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney.
      B Meister, A Dagerlind, A P Nicholas and T Hökfelt
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1605-1611;

  10. Meltzer, H Y

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;
    2. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
      H Y Meltzer, B L Chai, P A Thompson and B K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1452-1461;

  11. Metzger, W J

    1. Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor.
      S Ali, S J Mustafa and W J Metzger
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1328-1334;

  12. Mihara, S

    1. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139.
      S Mihara, S Nakajima, S Matumura, T Kohnoike and M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1122-1128;

  13. Mochizuki, K

    1. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
      H Echizen, K Mochizuki, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1518-1525;

  14. Monopoli, A

    1. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
      C Casati, A Monopoli, S Dionisotti, C Zocchi, E Bonizzoni and E Ongini
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1506-1511;

  15. Monsma, F J

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  16. Montastruc, J L

    1. Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
      M Berlan, J Galitzky, A Bousquet-Melou, M Lafontan and J L Montastruc
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1444-1451;

  17. Müller, F

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  18. Mustafa, S J

    1. Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor.
      S Ali, S J Mustafa and W J Metzger
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1328-1334;

N

  1. Naka, T

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  2. Nakajima, S

    1. Pharmacological characterization of a potent nonpeptide endothelin receptor antagonist, 97-139.
      S Mihara, S Nakajima, S Matumura, T Kohnoike and M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1122-1128;

  3. Nambi, P

    1. Characterization of canine renal endothelin receptor subtypes and their function.
      D P Brooks, P D DePalma, M Pullen and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1091-1097;

  4. Newport, G D

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  5. Nicholas, A P

    1. Patterns of messenger RNA expression for adrenergic receptor subtypes in the rat kidney.
      B Meister, A Dagerlind, A P Nicholas and T Hökfelt
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1605-1611;

  6. Nishi, H

    1. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.
      T Watanabe, S Yuki, M Egawa and H Nishi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1597-1604;

  7. Noda, T

    1. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
      C P Cheng, T Noda, M Nordlander, M Ohno and W C Little
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1232-1241;

  8. Nordlander, M

    1. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
      C P Cheng, T Noda, M Nordlander, M Ohno and W C Little
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1232-1241;

O

  1. O'Rourke, M F

    1. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes.
      M F O'Rourke, H S Blaxall, L J Iversen and D B Bylund
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1362-1367;

  2. Ohno, M

    1. Comparison of effects of dihydropyridine calcium antagonists on left ventricular systolic and diastolic performance.
      C P Cheng, T Noda, M Nordlander, M Ohno and W C Little
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1232-1241;

  3. Ohtsuki, K

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  4. Ojima, M

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  5. Ongini, E

    1. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
      C Casati, A Monopoli, S Dionisotti, C Zocchi, E Bonizzoni and E Ongini
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1506-1511;

  6. Osinski, M A

    1. Increased active stress generation of denervated rat intestinal smooth muscle: functional analysis of muscarinic receptor population.
      M A Osinski and P Bass
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1368-1373;

  7. Owyang, C

    1. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.
      W L Hasler, H C Soudah and C Owyang
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1206-1211;

P

  1. Pappano, A J

    1. Distinct modes of inhibition by ruthenium red and ryanodine of calcium-induced calcium release in avian atrium.
      A M Vites and A J Pappano
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1476-1484;

  2. Partilla, J S

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  3. Perretti, M

    1. Anti-inflammatory effect of prostanoids in mouse and rat skin: evidence for a role of EP3-receptors.
      A Ahluwalia and M Perretti
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1526-1531;

  4. Pessah, I N

    1. Antithetical actions of mitoxantrone and doxorubicin on ryanodine-sensitive Ca++ release channels of rat cardiac sarcoplasmic reticulum: evidence for a competitive mechanism.
      E Kim, S N Giri and I N Pessah
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1212-1221;

  5. Petitclerc, E

    1. Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade.
      E Petitclerc, P E Poubelle and F Marceau
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1419-1425;

  6. Picker, M J

    1. Kappa agonist and antagonist properties of mixed action opioids in a pigeon drug discrimination procedure.
      M J Picker
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1190-1198;

  7. Piercey, M F

    1. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
      M F Piercey, M W Smith and J T Lum-Ragan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1297-1303;
    2. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  8. Post, R M

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  9. Poubelle, P E

    1. Rapid protein synthesis and turnover is involved in interleukin-1-induced relaxation of the rabbit isolated mesenteric artery. Analysis of the arachidonate cascade.
      E Petitclerc, P E Poubelle and F Marceau
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1419-1425;

  10. Printz, M P

    1. A unique central cholinergic deficit in the spontaneously hypertensive rat: physostigmine reveals a bradycardia associated with sensory stimulation.
      B K Taylor, D Holloway and M P Printz
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1081-1090;

  11. Provost, P

    1. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
      G Rousseau, P Provost, D Tran, G Caillé and J G Latour
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1252-1260;

  12. Pullen, M

    1. Characterization of canine renal endothelin receptor subtypes and their function.
      D P Brooks, P D DePalma, M Pullen and P Nambi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1091-1097;

  13. Putzien, O

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

Q

  1. Quon, C Y

    1. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
      D D Christ, P C Wong, Y N Wong, S D Hart, C Y Quon and G N Lam
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1199-1205;

R

  1. Rady, J J

    1. The heroin metabolite, 6-monoacetylmorphine, activates delta opioid receptors to produce antinociception in Swiss-Webster mice.
      J J Rady, F Aksu and J M Fujimoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1222-1231;

  2. Rangachari, P K

    1. Functional subtyping of neurokinin receptors on canine proximal colonic mucosa.
      R Crowther, D Jukic, D Regoli and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1374-1380;

  3. Ransom, J T

    1. Characterization of the alpha-1 adrenoceptor subtype mediating [3H]-arachidonic acid release and calcium mobilization in Madin-Darby canine kidney cells.
      D R Blue, D A Craig, J T Ransom, J A Camacho, P A Insel and D E Clarke
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1588-1596;

  4. Regoli, D

    1. Functional subtyping of neurokinin receptors on canine proximal colonic mucosa.
      R Crowther, D Jukic, D Regoli and P K Rangachari
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1374-1380;

  5. Rice, K C

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  6. Robertson, L W

    1. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
      P N Zannikos, A M Bandyopadhyay, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1565-1570;

  7. Rosen, D

    1. Calcium channel blockers modify electrophysiological effects induced by lytic granules from cytotoxic T lymphocytes in guinea pig ventricular myocytes.
      O Binah, G Berke, D Rosen and B F Hoffman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1581-1587;

  8. Roth, B L

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  9. Rothman, R B

    1. Studies of the biogenic amine transporters. III. Demonstration of two binding sites for [3H]GBR12935 and [3H]BTCP in rat caudate membranes.
      H C Akunne, C M Dersch, J L Cadet, M H Baumann, G U Char, J S Partilla, B R de Costa, K C Rice, F I Carroll and R B Rothman
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1462-1475;

  10. Rousseau, G

    1. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
      G Rousseau, P Provost, D Tran, G Caillé and J G Latour
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1252-1260;

S

  1. Sabouraud, A

    1. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
      F Audebert, M Urtizberea, A Sabouraud, J M Scherrmann and C Bon
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1512-1517;

  2. Sanada, T

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  3. Scherrmann, J M

    1. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
      F Audebert, M Urtizberea, A Sabouraud, J M Scherrmann and C Bon
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1512-1517;

  4. Schmued, L

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  5. Schreur, P J

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  6. Sebastian, A

    1. 5 beta-Methyl-14 beta-(p-nitrocinnamoylamino)-7,8-dihydromorphinone and its corresponding N-cyclopropylmethyl analog, N-cyclopropylmethylnor-5 beta-methyl-14 beta-(p-nitrocinnamoylamino)- 7,8-dihydromorphinone: mu-selective irreversible opioid antagonists.
      Q Jiang, A Sebastian, S Archer and J M Bidlack
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1107-1113;

  7. Seifen, E

    1. Effects of WB4101 and chloroethylclonidine on the positive and negative inotropic actions of phenylephrine in rat cardiac muscle.
      A P Williamson, E Seifen, J P Lindemann and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1174-1182;

  8. Shader, R I

    1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
      L L von Moltke, D J Greenblatt, M M Cotreau-Bibbo, S X Duan, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1278-1283;

  9. Shaw, K

    1. Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors.
      M A Harrington, K Shaw, P Zhong and R D Ciaranello
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1098-1106;

  10. Shen, Y

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  11. Shibouta, Y

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  12. Sibley, D R

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  13. Slikker, W

    1. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
      J F Bowyer, D L Davies, L Schmued, H W Broening, G D Newport, W Slikker and R R Holson
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1571-1580;

  14. Smith, M W

    1. Excitation of noradrenergic cell firing by 5-hydroxytryptamine1A agonists correlates with dopamine antagonist properties.
      M F Piercey, M W Smith and J T Lum-Ragan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1297-1303;

  15. Smith, P B

    1. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
      P B Smith, S P Welch and B R Martin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1381-1387;

  16. Smith, P G

    1. Parasympathetic innervation of rat peri-orbital smooth muscle: prejunctional cholinergic inhibition of sympathetic neurotransmission without direct postjunctional actions.
      C L Beauregard and P G Smith
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1284-1288;

  17. Somogyi, A A

    1. Interaction of the stereoisomers of basic drugs with the uptake of tetraethylammonium by rat renal brush-border membrane vesicles.
      A S Gross and A A Somogyi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1073-1080;

  18. Soudah, H C

    1. Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients.
      W L Hasler, H C Soudah and C Owyang
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1206-1211;

  19. Specter, S

    1. The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells.
      S Diaz, S Specter, J Y Vanderhoek and R G Coffey
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1289-1296;

  20. Stem, J L

    1. Contraction of the guinea pig isolated, perfused trachea to purine and pyrimidine agonists.
      J S Fedan, J L Stem and B Day
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1321-1327;

  21. Stula, M

    1. The influence of desipramine on thyroid hormone metabolism in rat brain.
      A Campos-Barros, H Meinhold, M Stula, F Müller, R Köhler, M Eravci, O Putzien and A Baumgartner
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1143-1152;

  22. Sze, P Y

    1. Ethanol modulates [125I]calmodulin binding to synaptic plasma membranes from rat brain.
      P Y Sze and Z Iqbal
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1183-1189;

T

  1. Tang, A H

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

  2. Tani, M

    1. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes.
      H Echizen, K Mochizuki, M Tani and T Ishizaki
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1518-1525;

  3. Taub, M

    1. Uptake and phosphorylation of thiamine in rabbit primary proximal tubule cells and Madin Darby canine kidney cells. II. Effect of ethanol.
      M A Mahajan, M Acara and M Taub
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1316-1320;

  4. Taylor, B K

    1. A unique central cholinergic deficit in the spontaneously hypertensive rat: physostigmine reveals a bradycardia associated with sensory stimulation.
      B K Taylor, D Holloway and M P Printz
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1081-1090;

  5. Taylor, D A

    1. Functional distribution and role of alpha-1 adrenoceptor subtypes in the mesenteric vasculature of the rat.
      J Q Kong, D A Taylor and W W Fleming
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1153-1159;

  6. Thompson, P A

    1. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
      H Y Meltzer, B L Chai, P A Thompson and B K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1452-1461;

  7. Tran, D

    1. Clentiazem given at reperfusion improves subendocardial reflow and reduces myocardial infarct size in the dog.
      G Rousseau, P Provost, D Tran, G Caillé and J G Latour
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1252-1260;

  8. Trettau, J

    1. Effects of local anesthetics on experiential, physiologic and endocrine measures in healthy humans and on rat hypothalamic corticotropin-releasing hormone release in vitro: clinical and psychobiologic implications.
      M A Kling, D L Gardner, A E Calogero, R Coppola, J Trettau, C H Kellner, L Lefter, M J Hart, R W Cowdry and R M Post
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1548-1564;

  9. Tsai, B S

    1. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
      B S Tsai, R H Keith, D Villani-Price, R A Haack and S W Djuric
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1493-1498;
    2. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

U

  1. Uluer, A

    1. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.
      B L Roth, S C Craigo, M S Choudhary, A Uluer, F J Monsma, Y Shen, H Y Meltzer and D R Sibley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1403-1410;

  2. Urtizberea, M

    1. Pharmacokinetics of Vipera aspis venom after experimental envenomation in rabbits.
      F Audebert, M Urtizberea, A Sabouraud, J M Scherrmann and C Bon
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1512-1517;

V

  1. Vanderhoek, J Y

    1. The effect of delta-9-tetrahydrocannabinol on arachidonic acid metabolism in human peripheral blood mononuclear cells.
      S Diaz, S Specter, J Y Vanderhoek and R G Coffey
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1289-1296;

  2. Vantalon, V

    1. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
      T Jolas, S Haj-Dahmane, E J Kidd, X Langlois, L Lanfumey, C M Fattaccini, V Vantalon, A M Laporte, J Adrien and H Gozlan
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1432-1443;

  3. Villani-Price, D

    1. The leukotriene B4 receptor agonist/antagonist activities of SC-45694 in human neutrophils.
      B S Tsai, R H Keith, D Villani-Price, R A Haack and S W Djuric
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1493-1498;
    2. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

  4. Vites, A M

    1. Distinct modes of inhibition by ruthenium red and ryanodine of calcium-induced calcium release in avian atrium.
      A M Vites and A J Pappano
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1476-1484;

  5. von Moltke, L L

    1. Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.
      L L von Moltke, D J Greenblatt, M M Cotreau-Bibbo, S X Duan, J S Harmatz and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1278-1283;

  6. VonVoigtlander, P F

    1. Pharmacology of a mixed 5-hydroxytryptamine1A/dopamine agonist.
      M F Piercey, A H Tang, R A Lahti, P F VonVoigtlander, P J Schreur, R B McCall, J T Lum-Ragan, W E Hoffmann, S R Franklin and R A Code
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1304-1310;

W

  1. Wada, T

    1. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
      Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;

  2. Walle, T

    1. Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation.
      G N Kumar, U K Walle and T Walle
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1160-1165;

  3. Walle, U K

    1. Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation.
      G N Kumar, U K Walle and T Walle
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1160-1165;

  4. Wang, Y

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  5. Watanabe, T

    1. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.
      T Watanabe, S Yuki, M Egawa and H Nishi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1597-1604;

  6. Weiner, J L

    1. Potentiation of GABAA-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C.
      J L Weiner, L Zhang and P L Carlen
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1388-1395;

  7. Welch, S P

    1. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.
      P B Smith, S P Welch and B R Martin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1381-1387;

  8. Williamson, A P

    1. Effects of WB4101 and chloroethylclonidine on the positive and negative inotropic actions of phenylephrine in rat cardiac muscle.
      A P Williamson, E Seifen, J P Lindemann and R H Kennedy
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1174-1182;

  9. Wong, P C

    1. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
      D D Christ, P C Wong, Y N Wong, S D Hart, C Y Quon and G N Lam
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1199-1205;

  10. Wong, Y N

    1. The pharmacokinetics and pharmacodynamics of the angiotensin II receptor antagonist losartan potassium (DuP 753/MK 954) in the dog.
      D D Christ, P C Wong, Y N Wong, S D Hart, C Y Quon and G N Lam
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1199-1205;

  11. Wright, K F

    1. Discrimination of A1 versus A2 receptor subtype selectivity of adenosine receptor agonists in vivo.
      R J Barrett, D A Droppleman and K F Wright
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1166-1173;

X

  1. Xie, J

    1. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
      S S Greenberg, A Johns, J Kleha, J Xie, Y Wang, J Bianchi and K Conley
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1352-1361;

  2. Xu, X

    1. A selective blocker for rested T-type Ca++ channels in guinea pig atrial cells.
      X Xu and K S Lee
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1135-1142;

Y

  1. Yamamoto, B K

    1. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
      H Y Meltzer, B L Chai, P A Thompson and B K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1452-1461;

  2. Yang, D C

    1. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

  3. Yu, S

    1. The in vitro pharmacology of SC-51146: a potent antagonist of leukotriene B4 receptors.
      B S Tsai, R H Keith, D Villani-Price, J F Kachur, D C Yang, S W Djuric and S Yu
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1499-1505;

  4. Yuki, S

    1. Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.
      T Watanabe, S Yuki, M Egawa and H Nishi
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1597-1604;

Z

  1. Zannikos, P N

    1. Cytochrome P450 2B enzyme induction defect after 2,2',4,4',5,5'-hexachlorobiphenyl treatment in the fa/fa Zucker rat.
      P N Zannikos, A M Bandyopadhyay, L W Robertson and R A Blouin
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1565-1570;

  2. Zhang, A

    1. Cocaine-induced cerebrovasospasm and its possible mechanism of action.
      G Q He, A Zhang, B T Altura and B M Altura
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1532-1539;

  3. Zhang, L

    1. Potentiation of GABAA-mediated synaptic current by ethanol in hippocampal CA1 neurons: possible role of protein kinase C.
      J L Weiner, L Zhang and P L Carlen
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1388-1395;

  4. Zhong, P

    1. Agonist-induced desensitization and loss of high-affinity binding sites of stably expressed human 5-HT1A receptors.
      M A Harrington, K Shaw, P Zhong and R D Ciaranello
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1098-1106;

  5. Zocchi, C

    1. Repeated administration of selective adenosine A1 and A2 receptor agonists in the spontaneously hypertensive rat: tolerance develops to A1-mediated hemodynamic effects.
      C Casati, A Monopoli, S Dionisotti, C Zocchi, E Bonizzoni and E Ongini
      Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1506-1511;
Back to top

In this issue